Identification of BRAF 3′UTR Isoforms in Melanoma

作者: Andrea Marranci , Andrea Tuccoli , Marianna Vitiello , Elisa Mercoledi , Samanta Sarti

DOI: 10.1038/JID.2015.47

关键词:

摘要:

参考文章(14)
Minjing Zou, Essa Y. Baitei, Ali S. Alzahrani, Futwan Al-Mohanna, Nadir R. Farid, Brian Meyer, Yufei Shi, Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors. Neoplasia. ,vol. 11, pp. 57- 65 ,(2009) , 10.1593/NEO.81044
Benjamin Hirschi, Frank T. Kolligs, Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer. International Journal of Cancer. ,vol. 133, pp. 590- 596 ,(2013) , 10.1002/IJC.28061
Laura Poliseno, Leonardo Salmena, Jiangwen Zhang, Brett Carver, William J. Haveman, Pier Paolo Pandolfi, A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature. ,vol. 465, pp. 1033- 1038 ,(2010) , 10.1038/NATURE09144
David Dankort, David P Curley, Robert A Cartlidge, Betsy Nelson, Anthony N Karnezis, William E Damsky Jr, Mingjian J You, Ronald A DePinho, Martin McMahon, Marcus Bosenberg, BrafV600E cooperates with Pten loss to induce metastatic melanoma Nature Genetics. ,vol. 41, pp. 544- 552 ,(2009) , 10.1038/NG.356
Shanker Kalyana-Sundaram, Chandan Kumar-Sinha, Sunita Shankar, Dan R Robinson, Yi-Mi Wu, Xuhong Cao, Irfan A Asangani, Vishal Kothari, John R Prensner, Robert J Lonigro, Matthew K Iyer, Terrence Barrette, Achiraman Shanmugam, Saravana M Dhanasekaran, Nallasivam Palanisamy, Arul M Chinnaiyan, None, Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers Cell. ,vol. 149, pp. 1622- 1634 ,(2012) , 10.1016/J.CELL.2012.04.041
L N Kwong, M A Davies, Targeted therapy for melanoma: rational combinatorial approaches. Oncogene. ,vol. 33, pp. 1- 9 ,(2014) , 10.1038/ONC.2013.34
Min Hee Lee, Seong Eun Lee, Dong Wook Kim, Min Jeong Ryu, Sung Jin Kim, Sung Joong Kim, Yong Kyoung Kim, Ji Hoon Park, Gi Ryang Kweon, Jin Man Kim, Jung Uee Lee, Valentina De Falco, Young Suk Jo, Minho Shong, Mitochondrial Localization and Regulation of BRAFV600E in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAFV600E The Journal of Clinical Endocrinology and Metabolism. ,vol. 96, pp. 2242- 2242 ,(2010) , 10.1210/JC.2010-1071
D. Matallanas, M. Birtwistle, D. Romano, A. Zebisch, J. Rauch, A. von Kriegsheim, W. Kolch, Raf Family Kinases: Old Dogs Have Learned New Tricks Genes & Cancer. ,vol. 2, pp. 232- 260 ,(2011) , 10.1177/1947601911407323
Brenden Chen, Christine Tardell, Brian Higgins, Kathryn Packman, John F. Boylan, Huifeng Niu, BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines PLoS ONE. ,vol. 7, pp. e42598- ,(2012) , 10.1371/JOURNAL.PONE.0042598
Poulikos I. Poulikakos, Yogindra Persaud, Manickam Janakiraman, Xiangju Kong, Charles Ng, Gatien Moriceau, Hubing Shi, Mohammad Atefi, Bjoern Titz, May Tal Gabay, Maayan Salton, Kimberly B. Dahlman, Madhavi Tadi, Jennifer A. Wargo, Keith T. Flaherty, Mark C. Kelley, Tom Misteli, Paul B. Chapman, Jeffrey A. Sosman, Thomas G. Graeber, Antoni Ribas, Roger S. Lo, Neal Rosen, David B. Solit, RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) Nature. ,vol. 480, pp. 387- 390 ,(2011) , 10.1038/NATURE10662